BACKGROUND: We sought to assess the relationship between bacterial vaginosis (BV) assessed by Gram stain and incident trichomonal, gonococcal, and/or chlamydial genital infection. METHODS: This longitudinal study included 3620 nonpregnant women aged 15-44 years who presented for routine care at 12 clinics in Birmingham, Alabama. Participants were assessed quarterly for 1 year. Vaginal smears were categorized by the Nugent Gram stain score (0-3, normal; 4-6, intermediate state; 7-10, BV). Pooled logistic regression was used to estimate the hazard ratios for the comparison of trichomonal, gonococcal, and chlamydial infection incidence in participants by Nugent score at the prior visit. Participants were censored at their first visit with a positive test result for trichomonal, gonococcal, and/or chlamydial infection. RESULTS: Of the 10,606 eligible visits, 37.96% were classified by BV and 13.3% by positive detection of trichomonal, gonococcal, and/or chlamydial infection. An intermediate state or BV at the prior visit was associated with a 1.5-2-fold increased risk for incident trichomonal, gonococcal, and/or chlamydial infection (adjusted hazard ratio [AHR] for intermediate state, 1.41 [95% confidence interval {CI}, 1.12-1.76]; AHR for BV, 1.73 [95% CI, 1.42-2.11]; P= .058 for trend). Estimates were similar for trichomonal-only, gonococcal-only, and chlamydial-only infection outcomes. CONCLUSION: BV microbiota as gauged by Gram stain is associated with a significantly elevated risk for acquisition of trichomonal, gonococcal, and/or chlamydial genital infection.
BACKGROUND: We sought to assess the relationship between bacterial vaginosis (BV) assessed by Gram stain and incident trichomonal, gonococcal, and/or chlamydial genital infection. METHODS: This longitudinal study included 3620 nonpregnant women aged 15-44 years who presented for routine care at 12 clinics in Birmingham, Alabama. Participants were assessed quarterly for 1 year. Vaginal smears were categorized by the Nugent Gram stain score (0-3, normal; 4-6, intermediate state; 7-10, BV). Pooled logistic regression was used to estimate the hazard ratios for the comparison of trichomonal, gonococcal, and chlamydial infection incidence in participants by Nugent score at the prior visit. Participants were censored at their first visit with a positive test result for trichomonal, gonococcal, and/or chlamydial infection. RESULTS: Of the 10,606 eligible visits, 37.96% were classified by BV and 13.3% by positive detection of trichomonal, gonococcal, and/or chlamydial infection. An intermediate state or BV at the prior visit was associated with a 1.5-2-fold increased risk for incident trichomonal, gonococcal, and/or chlamydial infection (adjusted hazard ratio [AHR] for intermediate state, 1.41 [95% confidence interval {CI}, 1.12-1.76]; AHR for BV, 1.73 [95% CI, 1.42-2.11]; P= .058 for trend). Estimates were similar for trichomonal-only, gonococcal-only, and chlamydial-only infection outcomes. CONCLUSION: BV microbiota as gauged by Gram stain is associated with a significantly elevated risk for acquisition of trichomonal, gonococcal, and/or chlamydial genital infection.
Authors: Jack D Sobel; Daron Ferris; Jane Schwebke; Paul Nyirjesy; Harold C Wiesenfeld; Jeffrey Peipert; David Soper; Suzanne E Ohmit; Sharon L Hillier Journal: Am J Obstet Gynecol Date: 2006-04-21 Impact factor: 8.661
Authors: Mark A Klebanoff; Jane R Schwebke; Jun Zhang; Tonja R Nansel; Kai-Fun Yu; William W Andrews Journal: Obstet Gynecol Date: 2004-08 Impact factor: 7.661
Authors: Janneke H H M van de Wijgert; Charles S Morrison; Joelle Brown; Cynthia Kwok; Barbara Van Der Pol; Tsungai Chipato; Josaphat K Byamugisha; Nancy Padian; Robert A Salata Journal: Sex Transm Dis Date: 2009-06 Impact factor: 2.830
Authors: Eve Rose; Ralph J Diclemente; Gina M Wingood; Jessica McDermott Sales; Teaniese P Latham; Richard A Crosby; Jonathan Zenilman; Johan Melendez; James Hardin Journal: Arch Pediatr Adolesc Med Date: 2009-01
Authors: Matthew K Muramatsu; Julie A Brothwell; Barry D Stein; Timothy E Putman; Daniel D Rockey; David E Nelson Journal: Infect Immun Date: 2016-09-19 Impact factor: 3.441
Authors: Anne L Dunlop; Jennifer G Mulle; Erin P Ferranti; Sara Edwards; Alexis B Dunn; Elizabeth J Corwin Journal: Adv Neonatal Care Date: 2015-12 Impact factor: 1.968
Authors: Jennifer E Balkus; Lisa E Manhart; Jeannette Lee; Omu Anzala; Joshua Kimani; Jane Schwebke; Juma Shafi; Charles Rivers; Emanuel Kabare; R Scott McClelland Journal: J Infect Dis Date: 2016-02-04 Impact factor: 5.226
Authors: Rita T Brookheart; Warren G Lewis; Jeffrey F Peipert; Amanda L Lewis; Jenifer E Allsworth Journal: Am J Obstet Gynecol Date: 2019-01-29 Impact factor: 8.661
Authors: Charlotte A Gaydos; Mary Jett-Goheen; Mathilda Barnes; Laura Dize; Perry Barnes; Yu-Hsiang Hsieh Journal: Sex Transm Infect Date: 2015-08-18 Impact factor: 3.519
Authors: Jane R Schwebke; Jeannette Y Lee; Shelly Lensing; Susan S Philip; Harold C Wiesenfeld; Arlene C Seña; Nikole Trainor; Nincoshka Acevado; Lisa Saylor; Ann M Rompalo; Robert L Cook Journal: Clin Infect Dis Date: 2015-11-26 Impact factor: 9.079